BASILE, DEBORA
 Distribuzione geografica
Continente #
NA - Nord America 1.089
EU - Europa 157
AS - Asia 100
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.350
Nazione #
US - Stati Uniti d'America 1.086
IT - Italia 60
CN - Cina 44
UA - Ucraina 23
IE - Irlanda 22
VN - Vietnam 22
DE - Germania 17
SG - Singapore 16
IN - India 9
BE - Belgio 8
SE - Svezia 7
GB - Regno Unito 6
IR - Iran 6
CZ - Repubblica Ceca 5
FR - Francia 4
RU - Federazione Russa 4
CA - Canada 3
HK - Hong Kong 2
CL - Cile 1
EG - Egitto 1
EU - Europa 1
RO - Romania 1
TG - Togo 1
TR - Turchia 1
Totale 1.350
Città #
Fairfield 156
Chandler 147
Ashburn 116
Woodbridge 63
Ann Arbor 57
Seattle 57
Houston 52
Wilmington 47
Cambridge 40
Beijing 28
New York 25
Princeton 24
Dong Ket 22
Dublin 22
Martignacco 20
Dearborn 17
Singapore 14
San Diego 11
Washington 11
Jacksonville 10
Brussels 8
Ogden 8
Udine 7
Ardabil 5
Bologna 5
Leawood 5
Los Angeles 5
Norwalk 5
Brno 4
Dallas 4
Redmond 4
Boardman 3
Caserta 3
Des Moines 3
Jinan 3
Milan 3
Nanjing 3
Toronto 3
Augusta 2
Clifton 2
Edinburgh 2
Hong Kong 2
Munich 2
Phoenix 2
San Mateo 2
Wenzhou 2
Asti 1
Bangalore 1
Boston 1
Cairo 1
Catania 1
Chengdu 1
Duncan 1
Florence 1
Fuzhou 1
Grafing 1
Hefei 1
Hyderabad 1
Izmir 1
Kunming 1
Langfang 1
Lomé 1
Lviv 1
Mortegliano 1
Moscow 1
Nanchang 1
Naples 1
Paris 1
Partanna 1
Prague 1
Redwood City 1
Romans 1
Rutigliano 1
San Francisco 1
Shenzhen 1
Trento 1
Trieste 1
Tuenno 1
Wuhan 1
Totale 1.069
Nome #
Characterizing metastatic HER2-positive gastric cancer at the CDH1 haplotype 139
Androgen receptor in estrogen receptor positive breast cancer: Beyond expression 105
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 99
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 97
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 89
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 84
Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Cutaneous Melanoma 82
Monitoring metastatic breast cancer (M-MBC) during treatment: a GIM (Gruppo Italiano Mammella) survey 67
Neutrophil-to-lymphocyte ratio in metastatic breast cancer patients: relationship with tumor characteristics and survival 63
Sarcopenia: looking to muscle mass to better manage pancreatic cancer patients 61
Small luminal-like breast cancer: determinants of adjuvant chemotherapy use 61
Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer 57
Time to surgery after neoadjuvant chemotherapy for early breast cancer 51
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis 43
Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application 41
Lactate dehydrogenase as a prognostic biomarker in patients with hormone receptor-positive metastatic breast cancer treated with palbociclib: An exploratory cohort study 39
Perspectives in the Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer Patients 38
The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer 36
Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study 32
Determinants of choice in offering drug holidays during first-line therapy for metastatic colorectal cancer 32
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study 30
First-line chemotherapy with raltitrexed in metastatic colorectal cancer: an Association des Gastro-entérologues Oncologues (AGEO) multicentre study 25
Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice 22
How I treat stage II colon cancer patients 22
State-of-the-art of monoclonal antibodies for the treatment of gastric cancer 12
Totale 1.427
Categoria #
all - tutte 6.418
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.418


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020341 0 16 13 32 28 40 32 48 60 29 32 11
2020/2021334 18 9 24 51 32 20 12 44 8 27 38 51
2021/2022230 26 24 3 7 10 3 16 8 1 25 82 25
2022/2023298 25 39 8 28 35 58 1 28 50 4 12 10
2023/2024179 20 5 12 11 22 67 0 7 15 6 0 14
2024/202518 13 5 0 0 0 0 0 0 0 0 0 0
Totale 1.427